Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 888,798
  • Shares Outstanding, K 45,370
  • Annual Sales, $ 719,890 K
  • Annual Income, $ 98,090 K
  • EBIT $ 140 M
  • EBITDA $ 200 M
  • 60-Month Beta 0.93
  • Price/Sales 1.21
  • Price/Cash Flow 4.52
  • Price/Book 1.12

Options Overview Details

View History
  • Implied Volatility 73.12% (+15.86%)
  • Historical Volatility 87.48%
  • IV Percentile 59%
  • IV Rank 32.33%
  • IV High 151.74% on 03/23/26
  • IV Low 35.55% on 08/18/25
  • Expected Move (DTE 15) 3.30 (16.29%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 1,185
  • Open Int (30-Day) 1,523
  • Expected Range 16.94 to 23.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.60
  • Number of Estimates 1
  • High Estimate $0.60
  • Low Estimate $0.60
  • Prior Year $0.61
  • Growth Rate Est. (year over year) -1.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.03 +18.85%
on 03/12/26
21.14 -4.26%
on 03/02/26
+0.01 (+0.05%)
since 02/27/26
3-Month
17.03 +18.85%
on 03/12/26
29.52 -31.44%
on 01/12/26
-6.54 (-24.42%)
since 12/31/25
52-Week
17.03 +18.85%
on 03/12/26
31.26 -35.26%
on 09/02/25
-8.05 (-28.46%)
since 04/01/25

Most Recent Stories

More News
3 of Wall Street’s Favorite Stocks We Think Twice About

3 of Wall Street’s Favorite Stocks We Think Twice About

BWIN : 21.53 (-1.87%)
RH : 112.85 (-19.29%)
AMPH : 20.24 (+3.32%)
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NTRA : 203.21 (+1.61%)
NEO : 7.75 (+4.45%)
AMPH : 20.24 (+3.32%)
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN : 18.56 (+1.20%)
EVH : 2.22 (-2.63%)
RGEN : 118.32 (+0.42%)
AMPH : 20.24 (+3.32%)
RDNT : 55.31 (-1.04%)
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)

Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)

AMPH : 20.24 (+3.32%)
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today

Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today

AMPH : 20.24 (+3.32%)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%

AMPH : 20.24 (+3.32%)
Amphastar: Q4 Earnings Snapshot

Amphastar: Q4 Earnings Snapshot

AMPH : 20.24 (+3.32%)
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect

Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect

AMPH : 20.24 (+3.32%)
1 Value Stock on Our Watchlist and 2 We Turn Down

1 Value Stock on Our Watchlist and 2 We Turn Down

TROW : 89.87 (-0.30%)
BRZE : 23.58 (-0.13%)
AMPH : 20.24 (+3.32%)
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

OGN : 6.14 (+2.50%)
AMPH : 20.24 (+3.32%)
NVAX : 8.02 (-1.47%)

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 21.10
2nd Resistance Point 20.71
1st Resistance Point 20.47
Last Price 20.24
1st Support Level 19.84
2nd Support Level 19.45
3rd Support Level 19.21

See More

52-Week High 31.26
Fibonacci 61.8% 25.83
Fibonacci 50% 24.15
Fibonacci 38.2% 22.47
Last Price 20.24
52-Week Low 17.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.